In prostate cancer cells, FOXO3a has been shown to suppress β-catenin transcriptional activity and can be inhibited by AKT [336], whereas SOX4 is a positive regulator of canonical WNT and is stimulated by AKT [338] (Figure 4). This evidence concerns the gene AKT1 and prostate cancer.